Search Results
May 25, 2026, 22:52 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
groupSession Title: Late-Breaking Abstracts: Clinical ScienceDate/Time: Monday June 22, 2026, 15:57 PM-16:09 PM EDTLocation: 253-BC, Level 2, Thomas Michael Menino Convention and Exhibition CenterContacts for more information:Kerstin Falck, VP Global Corporate
More news about: Hansa Biopharma AB
May 25, 2026, 22:11 ET Silvercorp Files Listing Application with the Hong Kong Stock Exchange
Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, May 25, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American:
More news about: Silvercorp Metals Inc.
May 25, 2026, 11:18 ET TCL Zhonghuan Launches Next-Generation BC Module at Tianjin Manufacturing Base
next-generation BC (back-contact) high-efficiency module at its Tianjin manufacturing base this month, marking a major milestone as the company transitions BC technology from advanced development into large-scale commercial production. Featuring a unique combination of proprietary BC architecture
More news about: TCL Zhonghuan
May 25, 2026, 08:00 ET Zero Candida Announces Corporate Changes
VANCOUVER, BC, May 25, 2026 /CNW/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) (OTC: ZCTFF) an Israeli FemTech medical device start-up, wishes
More news about: Zero Candida
May 25, 2026, 08:00 ET Zero Candida Announces Corporate Changes
VANCOUVER, BC, May 25, 2026 /PRNewswire/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) (OTC: ZCTFF) an Israeli FemTech medical device start-up,
More news about: Zero Candida
May 25, 2026, 07:46 ET El Grupo Menarini anuncia nuevos datos en la Reunión Anual de la Sociedad Estadounidense de Oncología Clínica (asco) 2026
NCT06382948) es un ensayo aleatorizado, doble ciego de fase 3 que evalúa el elacestrant en combinación con everolimus en pacientes con CMM con ER+, HER2-BC con tumores ESR1-mut. ELEVATE (NCT05563220) es un ensayo
More news about: Menarini Industrie Farmaceutiche Riunite
May 23, 2026, 12:09 ET A BC.GAME atualiza o white paper do $BC, revelando novos detalhes sobre a utilidade do token e o mecanismo de queima
uso em torno de seu token nativo de plataforma, como também descreve o mecanismo de queima ligado à atividade de staking no BC Engine. Quando os usuários fazem stake de $BC no BC Engine e fazem unstake dessa porção antes de ela permanecer em staking por sete dias, 1% do valor retirado é direcionado para
More news about: BC.GAME
May 23, 2026, 12:06 ET BC.GAME werkt het $BC-whitepaper bij en onthult nieuwe details over het nut van de token en het burnmechanisme
toepassingen rond zijn eigen platformtoken, maar beschrijft ook het burnmechanisme dat gekoppeld is aan stakingactiviteiten binnen de BC Engine. Wanneer spelers $BC staken in de BC Engine en die tokens binnen zeven dagen weer terughalen, wordt één percent van het opgenomen bedrag doorgestuurd naar het burnproces.$BC
More news about: BC.GAME
May 23, 2026, 12:02 ET BC.GAME aggiorna il white paper sul $BC, rivelando nuovi dettagli sull'utilità del token e sul meccanismo di burn
proprio token nativo della piattaforma, ma descrive anche il meccanismo di burn collegato all'attività di staking su BC Engine. Quando i giocatori effettuano lo staking del $BC su BC Engine e sbloccano quella porzione prima che siano trascorsi sette giorni dallo staking, l'1% dell'importo sbloccato verrà
More news about: BC.GAME
May 23, 2026, 11:58 ET BC.GAME actualiza el documento técnico del $BC en el que revela nuevos detalles sobre la utilidad del token y el mecanismo de quema
con el token nativo de su plataforma, sino que también describe el mecanismo de quema vinculado a la actividad de staking de BC Engine. Cuando los jugadores depositan $BC en BC Engine y retiran esa parte antes de los siete días, el 1 % del monto retirado se dirige al proceso de quema.El $BC es
More news about: BC.GAME
May 22, 2026, 17:05 ET SILVERCORP DECLARES SEMI-ANNUAL DIVIDEND OF US$0.0125 PER SHARE
Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, May 22, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American:
More news about: Silvercorp Metals Inc.
May 22, 2026, 16:06 ET AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
1.09 %2) 1261229 BC Ltd. 10.00%, 04/15/32
More news about: AllianceBernstein Global High Income Fund, Inc.
May 22, 2026, 12:35 ET BC.GAME met à jour le livre blanc du $BC, révélant de nouveaux détails sur l'utilité du jeton et le mécanisme de combustion
d'utilisation autour de son jeton de plateforme natif, mais décrit également le mécanisme de combustion lié à l'activité de staking de BC Engine. Lorsque les joueurs stakeront des $BC dans BC Engine et déstakeront cette portion avant qu'elle n'ait été stakée pendant sept jours, 1 % du montant déstaké sera acheminé
More news about: BC.GAME
May 22, 2026, 11:33 ET BC.GAME actualiza el Libro Blanco de $BC: nuevos detalles sobre la utilidad del token y el mecanismo de quema
con su token nativo de la plataforma, sino que también describe el mecanismo de quema vinculado a la actividad de staking de BC Engine. Cuando los jugadores depositan $BC en BC Engine y retiran esa porción antes de que hayan transcurrido siete días, el 1 % del importe retirado se destinará al proceso
More news about: BC.GAME
May 22, 2026, 10:13 ET BC.GAME更新$BC白皮書 披露代幣應用價值與銷毀機制最新細節
2026年5月22日 /美通社/ -- BC.GAME已發佈新版$BC白皮書，進一步詳述了$BC作為該平台原生代幣的定位，及其應用價值、BC Engine集成和銷毀機制。
More news about: BC.GAME
May 22, 2026, 09:01 ET Falcon Gold Corp. Positioned in Emerging Ontario Gold Growth Corridor Following Agnico Eagle's $14 Billion Provincial Commitment
FG: TSX-VVANCOUVER, BC, May 22, 2026 /PRNewswire/ - Falcon Gold Corp. (TSXV: FG) (FSE: 3FA) (OTC-Pinks: FGLDF) ("Falcon" or the "Company") notes the growing momentum within
More news about: Falcon Gold Corp.
May 22, 2026, 08:30 ET Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence
Poster: 286.Association of patient-reported stress and depression symptoms with ER-specific tumor transcriptional signatures in breast cancer (BC). (Abstract 565) Session: Breast Cancer—Local/Regional/Adjuvant. Date/Time: Monday, June 1, 2026, 1:30 PM–4:30 PM CDT. Location: Hall A, Poster: 50.Association
More news about: Caris Life Sciences
May 22, 2026, 08:00 ET SILVERCORP CHANGES FISCAL 2026 FINANCIAL RESULTS RELEASE DATE TO MAY 26, 2026
Trading Symbol: TSX/NYSE AMERICAN: SVMVANCOUVER, BC, May 22, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American:
More news about: Silvercorp Metals Inc.
May 22, 2026, 07:00 ET BC.GAME lanza su campaña para la Copa de Fútbol 2026 con más de 2 millones de dólares en premios
https://mma.prnewswire.com/media/2984195/BC_GAME.jpgLogotipo - https://mma.prnewswire.com/media/2685837/BC_GAME_Logo.jpg
More news about: BC.GAME
May 22, 2026, 02:56 ET BC.GAME Updates $BC White Paper, Revealing New Details on Token Utility and Burn Mechanism
BC.GAME's plans for new features and use cases around its native platform token, but also describes the burn mechanism linked to BC Engine staking activity. When players stake $BC into BC Engine and unstake that portion before it has been staked for seven days, 1% of the unstaked amount will be routed into the
More news about: BC.GAME
May 22, 2026, 02:33 ET BC.GAME Updates $BC White Paper, Revealing New Details on Token Utility and Burn Mechanism
new features and use cases around its native platform token, but also describes the burn mechanism linked to BC Engine staking activity. When players stake $BC into BC Engine and unstake that portion before it has been staked for seven days, 1% of the unstaked amount will be routed into the
More news about: BC.GAME
May 21, 2026, 20:00 ET Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, breast cancer (BC), gastric cancer (GC), gynecological tumors and genitourinary tumors, among others. Sac-TMT is developed with a unique, bifunctional linker that maximizes
More news about: Kelun-Biotech
May 21, 2026, 16:05 ET LIONSGATE REPORTS RESULTS FOR FOURTH QUARTER FISCAL 2026
12-Month Library Revenue Topped $1 Billion for Third Straight Quarter SANTA MONICA, Calif. and VANCOUVER, BC, May 21, 2026 /PRNewswire/ -- Lionsgate Studios Corp. (NYSE: LION) today reported fourth quarter results for
More news about: Lionsgate
May 21, 2026, 11:30 ET Cassiar District Polymetallic System Funded For 2026 Drilling Inside Tightening Silver Market
into the silver-Pb-Zn-W-In repricing trade now reshaping the broader silver producer universeVANCOUVER, BC, May 21, 2026 /PRNewswire/ -- Equity
More news about: Equity Insider
May 21, 2026, 10:04 ET Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS
the Company has proprietary intellectual property rights, targeting advanced solid tumors such as non-small cell lung cancer (NSCLC), breast cancer (BC), gastric cancer (GC), gynecological tumors and genitourinary tumors, among others. Sac-TMT is developed with a unique, bifunctional linker that maximizes
More news about: Kelun-Biotech